Back to search
FDAFDA · Food and drugs·Recall number D-1035-2020

PrediniSONE Tablets, USP 5 mg, 48-count bottle, Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 0603-5337-31

Published March 25, 2020 · Recall initiated: March 4, 2020

Summary

FDA records drug Class III recall D-1035-2020, published March 25, 2020 and initiated March 4, 2020. Recalling firm: Par Pharmaceutical Inc.; Status: Terminated; Reported quantity: 13008 bottles; Lot: Lot #: 8672518, Exp 12/21. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Exp Date - An incorrect expiration date has been identified on Prednisone Tablets USP 5 mg

What to do

Voluntary: Firm initiated · Letter

Get an email if PREDNISONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PREDNISONE
Manufacturer
Par Pharmaceutical Inc.
Distributor
U.S.A. Nationwide
UPC
0306035338317
Lot
Lot #: 8672518, Exp 12/21
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PrediniSONE Tablets, USP 5 mg, 48-count bottle, Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 0603-5337-31 recalled?

Yes. FDA published recall D-1035-2020 on March 25, 2020. Reported hazard: Labeling: Incorrect or Missing Exp Date - An incorrect expiration date has been identified on Prednisone Tablets USP 5 mg

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PREDNISONE. UPC: 0306035338317.